Crypto market cap $2.04 T −6.35%24h volume $149.3 BBTC dominance 57.7%Fear & Greed 12/100BTC $58,306.50 −5.12%ETH $1,653.55 −4.68%S&P 500 (SPY) $689.81 −3.64%Gold $3,515.40 −4.61%Updated 2026-11-21
★ 💼

Biotech stocks: prices, market cap and charts

All Biotech stocks on one page: 20 assets with live prices, 24h change, market cap and how much $10 a day would have made.

Bio-TechneTECH
−0.04%
Bio-Techne · 24h
Regeneron PharmaceuticalsREGN
−0.18%
Regeneron Pharmaceuticals · 24h
Roivant SciencesROIV
−0.78%
Roivant Sciences · 24h
Celltrion068270
−0.93%
Celltrion · 24h
#NamePrice24h7dMarket capVolume (24h)Last 7 days
1Alnylam PharmaceuticalsALNY$143.82−2.71%−12.9%$19.26 B—→
2Arrowhead PharmaceuticalsARWR$41.37−5.22%−13.4%$6.09 B—→
3Bio-TechneTECH$72.67−0.04%−0.18%$11.42 B—→
4BioMarin PharmaceuticalBMRN$60.41−1.64%+5.56%$11.90 B—→
5Celltrion068270$159.58−0.93%−0.47%$36.41 B—→
6Corcept TherapeuticsCORT$63.62−2.09%−12.8%$7.42 B—→
7CSLCSL$130.59−1.28%−2.77%$63.17 B—→
8CytokineticsCYTK$50.78−1.32%−9.53%$7.15 B—→
9ExelixisEXEL$64.63−1.82%−6.33%$16.66 B—→
10HalozymeHALO$91.35−1.82%−8.90%$10.92 B—→
11IncyteINCY$114.63−1.07%−5.24%$23.62 B—→
12InsmedINSM$141.33−2.17%+16.6%$31.69 B—→
13Jazz PharmaceuticalsJAZZ$230.26−2.62%−4.67%$15.18 B—→
14Krystal BiotechKRYS$308.89−2.19%+1.20%$9.36 B—→
15ModernaMRNA$195.00−2.17%−12.7%$80.65 B—→
16Regeneron PharmaceuticalsREGN$920.69−0.18%−3.54%$95.24 B—→
17Roivant SciencesROIV$38.66−0.78%−2.21%$28.01 B—→
18Samsung Biologics207940$1,015.14−1.46%−3.97%$49.39 B—→
19Vertex PharmaceuticalsVRTX$515.02−1.08%−4.38%$136.01 B—→
20WuXi Biologics2269$5.23−6.57%−12.4%$21.49 B—→

All categories

Follow us
TelegramX (Twitter)BlueskyMediumPinterest✉ support@whatifstack.com🤝 partners@whatifstack.com
Popular
BitcoinEthereumSolanaXRPNvidiaAppleTeslaGoldS&P 500 ETFNasdaq-100 ETF
Markets
MarketsCompareCryptocurrencyStockETFMetalCommodityUnited KingdomCanadaAustraliaUnited StatesUkraine
Tools
CompareConverterLargest companiesFamous investorsLargest assetsMemecoinsCategoriesBitcoin halvingCalculators
Insights
GuideNewsInsightsRSSActivitiesExchangesAbout & methodologyEditorial policyPrivacyTermsFor partners & advertisers